Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,540.94
(
0.33%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

drbio45

Send PM Follow Ignore
Followers 36
Posts 3185
Boards Moderated 0
Alias Born 10/18/2003

drbio45

Re: croumagnon post# 53208

Thursday, 10/04/2007 7:34:01 PM

Thursday, October 04, 2007 7:34:01 PM

Post# of 257302
They both filed under the same parameters (missed primary but extended survival) and the DNDN data was a lot stronger than DORB's data... If you think DORB's case is unusual, and thus unpredictable, then for you DNDN's Provenge should have been a slam dunk approval...

you have a lot to learn if you think Provenge's data is stronger than orbec's
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today